Tag: Cancer: Rectal

Apart from colorectal cancer, increases in incidence were seen in both younger and older adults

Patients younger than 50 years diagnosed with EOCRC were more likely to have a benign colon indication, bleeding, and family history of CRC

Significantly lower incidence of colorectal cancer recurrence seen for patients with somatic alterations in PI3K pathway genes

In one health system, including personalized risk in a decision aid or provider notification increased uptake of stool testing

Positive associations seen for celiac disease, SLE, T1D with pancreatic, esophageal, colon, liver, and hepatobiliary cancers

Findings compared with three opt-in screening strategies among average-risk adults aged 45 to 49 years

Second study shows increase in up-to-date CRC screening prevalence

Just under half of patients receiving an abnormal blood test have follow-up colonoscopy in the short term

In study, patients with CRC as the only malignancy had more frequent liver and lung metastases and received systemic adjuvant treatments more often

Multitarget stool DNA testing was cost-effective relative to no screening, but CT colonography is cost-saving